SeekingAlpha · Aug 22, 2026
Centene Corporation: The Margin Recovery Is Real, And The Market Is Still Catching Up
Centene Corporation is executing a disciplined turnaround in government-sponsored healthcare. Find out why CNC stock is a buy.
NYSE · CNC
Centene Corporation
Healthcare · Medical - Healthcare Plans
$64.75
Down-$0.58 (-0.89%)
Updated Aug 31, 2026, 3:49 AM
SID Score
6.7/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 19.89B
- P/E ratio
- -3.76
- Dividend yield
- 0.00%
- 52-week range
- $31.63 – $69.36
- Volume
- 2.53M
- Avg. volume
- 10.62M
Price performance
CNC price history
1M range · 20 trading sessions · Daily adjusted prices
CNC closed at $64.75 after 20 trading sessions, up 1.55% for the selected period.
- Last close
- $64.75
- Period change
- +1.55%
- Period low
- $63.76
- Period high
- $67.47
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $65.41 | $65.74 | $64.28 | $64.75 | 2.53M |
| Aug 27, 2026 | $65.04 | $66.21 | $64.66 | $65.33 | 3.65M |
| Aug 26, 2026 | $65.00 | $67.68 | $64.98 | $65.47 | 3.6M |
| Aug 25, 2026 | $65.95 | $65.95 | $64.60 | $65.00 | 4.34M |
| Aug 24, 2026 | $64.79 | $66.10 | $64.52 | $65.65 | 3.49M |
| Aug 21, 2026 | $64.07 | $65.16 | $64.03 | $65.02 | 3.15M |
| Aug 20, 2026 | $63.73 | $64.87 | $63.47 | $64.14 | 3.27M |
| Aug 19, 2026 | $65.55 | $65.695 | $64.26 | $64.70 | 2.88M |
| Aug 18, 2026 | $64.89 | $65.94 | $64.72 | $65.22 | 3.41M |
| Aug 17, 2026 | $66.70 | $66.70 | $64.30 | $64.41 | 3.56M |
| Aug 14, 2026 | $66.165 | $67.615 | $65.85 | $67.47 | 2.27M |
| Aug 13, 2026 | $67.76 | $67.8399 | $65.72 | $66.04 | 3.54M |
| Aug 12, 2026 | $64.49 | $67.425 | $64.12 | $67.07 | 3.24M |
| Aug 11, 2026 | $67.72 | $67.859 | $64.74 | $64.88 | 2.44M |
| Aug 10, 2026 | $66.32 | $67.6675 | $65.92 | $66.57 | 3.72M |
| Aug 7, 2026 | $64.07 | $66.5199 | $63.945 | $65.77 | 3.53M |
| Aug 6, 2026 | $67.25 | $67.30 | $63.2064 | $64.20 | 5.47M |
| Aug 5, 2026 | $64.21 | $68.379 | $63.80 | $66.99 | 7.03M |
| Aug 4, 2026 | $64.30 | $64.755 | $63.48 | $64.07 | 6.03M |
| Aug 3, 2026 | $61.84 | $63.79 | $61.22 | $63.76 | 6.87M |
Latest CNC news
The latest Smart Investors Daily articles mentioning CNC.
Stock researchCompany · Overview
CNC research
Overview
Company profile and research snapshot.
Company profile
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Hold
- Average target
- $42.00
- Implied upside
- —
- Analysts
- 26
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 11, 2026 | Argus Research | Buy | — |
| Aug 4, 2026 | JP Morgan | Neutral | — |
| Aug 3, 2026 | Bernstein | Outperform | — |
| Jul 29, 2026 | Barclays | Overweight | — |
| Jul 29, 2026 | Baird | Neutral | — |
News briefing
No generated briefing is available yet.
Yahoo · Aug 21, 2026
Is The Pullback In UNH Stock A Glitch Or A Warning?
The healthcare giant is wrestling with costs in one part of its business, and the stock's recent dip has investors wondering if this is the moment to step in.
Yahoo · Aug 21, 2026
Coordinated Care Brings Free Health Screenings to Washington Communities with Statewide Vision & Dental Van Tour
Today, Coordinated Care, Washington's trusted healthcare partner and wholly owned subsidiary of the Centene Corporation (NYSE: CNC), is launching a nine-day, statewide healthcare tour, bringing Centene's vision and dental health vans, "SeeMore" and "Flossy," to communities across Washington.
Yahoo · Aug 21, 2026
The Bull Case For Centene (CNC) Could Change Following CFO Transition To Chris Neczypor – Learn Why
Centene Corporation recently announced that long-serving CFO Drew Asher will step down from his role at the end of 2026, with former Lincoln Financial executive Chris Neczypor set to join in September and assume the Executive Vice President and Chief Financial Officer position on January 1, 2027. The planned overlap between Asher and Neczypor, following a period in which Centene’s revenue grew from about US$126.00 billion in 2021 to about US$195.00 billion in 2025, highlights an emphasis on...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
